NCT04584112 2023-03-15A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast CancerHoffmann-La RochePhase 1 Completed83 enrolled